Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 430, pseudogene (RN7SL430P) is a human pseudogene derived from the 7SL RNA sequence, which primarily serves as the RNA component of the signal recognition particle (SRP) in protein targeting to membranes[1][3][6]. Unlike the functional 7SL RNA, RN7SL430P does not encode a protein or an active RNA with known cellular activity; it is a non-coding genomic sequence formed by reverse transcription and integration, resulting in a truncated, nonfunctional RNA copy[1][3]. Human DNA contains hundreds of such 7SL RNA-like pseudogenes, most of which are not expressed or functional[3][4]. While other pseudogenes have been shown to act as regulators of gene expression by acting as “miRNA decoys” or through competition for RNA-binding proteins, there is no evidence for RN7SL430P itself having such a role[2][3]. Currently, it is not considered a therapeutic target or biomarker by any major source[1][4][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 430, pseudogene (RN7SL430P).